Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAPTM4B - Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LAPTM4B - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LAPTM4B - Obese women with polycystic ovary syndrome and obese, healthy women: skeletal muscle
LAPTM4B - Alzheimer's disease: induced pluripotent stem cells with Presenilin 2 mutation (N141)
LAPTM4B - Angiopoietin-1 stimulation of vascular endothelial cells
LAPTM4B - Androgen deprivation effect on LNCaP prostate cancer cells: time course
LAPTM4B - Staufen1 deletion effect on mRNA abundance in HeLa cells
LAPTM4B - Imatinib effect on Philadelphia chromosome positive acute lymphoblastic leukemia cells
LAPTM4B - Isoflavone and 3,3’-diindolylmethane effect on C4-2B prostate cancer cells
LAPTM4B - BCL6 corepressor somatic mutation in acute myeloid leukemia with normal karyotype: Ficoll-enriched mononuclear cells
LAPTM4B - p53 mutations in microsatellite-stable, stage III colorectal cancer
LAPTM4B - Hepatitis C virus permissive cell lines Huh7.5 and HRP1 and non-permissive parent cell line Huh7
LAPTM4B - 3-Deazaneplanocin A effect on multiple myeloma cells
LAPTM4B - Small-molecule DOT1L inhibitor EPZ004777 effect on mixed lineage leukemia cells: time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on